Research ArticleArticle
Interactions between CYP2E1 and CYP2B4: Effects on Affinity for NADPH-Cytochrome P450 Reductase and Substrate Metabolism
Cesar Kenaan, Erin V. Shea, Hsia-lien Lin, Haoming Zhang, Matthew J. Pratt-Hyatt and Paul F. Hollenberg
Drug Metabolism and Disposition January 2013, 41 (1) 101-110; DOI: https://doi.org/10.1124/dmd.112.046094
Cesar Kenaan
Chemical Biology Doctoral Program, The University of Michigan, Ann Arbor, Michigan (C.K. and P.F.H.); Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan (C.K., E.V.S., H.L., H.Z. and P.F.H.); and Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas, Kansas City, Kansas (M.J.P.-H.)
Erin V. Shea
Chemical Biology Doctoral Program, The University of Michigan, Ann Arbor, Michigan (C.K. and P.F.H.); Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan (C.K., E.V.S., H.L., H.Z. and P.F.H.); and Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas, Kansas City, Kansas (M.J.P.-H.)
Hsia-lien Lin
Chemical Biology Doctoral Program, The University of Michigan, Ann Arbor, Michigan (C.K. and P.F.H.); Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan (C.K., E.V.S., H.L., H.Z. and P.F.H.); and Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas, Kansas City, Kansas (M.J.P.-H.)
Haoming Zhang
Chemical Biology Doctoral Program, The University of Michigan, Ann Arbor, Michigan (C.K. and P.F.H.); Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan (C.K., E.V.S., H.L., H.Z. and P.F.H.); and Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas, Kansas City, Kansas (M.J.P.-H.)
Matthew J. Pratt-Hyatt
Chemical Biology Doctoral Program, The University of Michigan, Ann Arbor, Michigan (C.K. and P.F.H.); Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan (C.K., E.V.S., H.L., H.Z. and P.F.H.); and Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas, Kansas City, Kansas (M.J.P.-H.)
Paul F. Hollenberg
Chemical Biology Doctoral Program, The University of Michigan, Ann Arbor, Michigan (C.K. and P.F.H.); Department of Pharmacology, The University of Michigan Medical School, Ann Arbor, Michigan (C.K., E.V.S., H.L., H.Z. and P.F.H.); and Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas, Kansas City, Kansas (M.J.P.-H.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
CYP2E1-CYP2B4 Interactions
Cesar Kenaan, Erin V. Shea, Hsia-lien Lin, Haoming Zhang, Matthew J. Pratt-Hyatt and Paul F. Hollenberg
Drug Metabolism and Disposition January 1, 2013, 41 (1) 101-110; DOI: https://doi.org/10.1124/dmd.112.046094
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement